Renal cell carcinoma of end-stage renal disease: An analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification

Modern Pathology

Volumn 12, Issue 3, 1999, Pages 301-309

  Hughson, Michael D ^a,b   Bigler, Steven ^b   Dickman, Kathleen ^a   Kovacs, Gyula ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cancer genetics; End stage renal disease; Renal cell carconoma

Indexed keywords

MICROSATELLITE DNA;

ARTICLE; CHROMOSOME 17; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 3; CHROMOSOME 3P; CHROMOSOME 3Q; CHROMOSOME 7; CHROMOSOME 7P; CHROMOSOME 7Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CLINICAL ARTICLE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; KIDNEY FAILURE; PRIORITY JOURNAL; TRISOMY;

ADOLESCENT; ADULT; AGED; ALLELES; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 17; CHROMOSOMES, HUMAN, PAIR 3; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 0033008097     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Doublet JD, Peraldi MN, Gattengo B, Thibault P, Sraer JD. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997;158:42-4.
2. Gulanikar AC, Dailey PP, Hamrick-Turner JE, Butkus DE. Prospective pretransplant ultrasound screening in 206 patients for acquired renal cysts and renal cell carcinoma. Transplantation. 1998;66:1669-72.
3. Seidman H, Silverberg BS, Bodden A. Probabilities of eventually developing and dying of cancer (risk among persons previously undiagnosed with the cancer). CA Cancer J Clin 1978;28:33-46.
4. Tosaka A, Ohya D, Yamada K, Ohashi H, Kitahara S, Sekine H, et al. Incidence and properties of renal masses and symptomatic renal cell carcinoma detected by abdominal ultrasonography. J Urol 1990;144:1097-9.
5. United States Renal Data Service. Annual data report. Am J Kidney Dis 1994;18:S12-S111.
6. The 1989 Report of the United States Renal Data System. V. Survival probabilities and causes of death. Am J Kidney Dis 1991;18(Suppl 2):49-60.
7. Port FK, Ragheb NE, Schwartz AG, Hawthorne VM. Neoplasms in dialysis patients: a population-based study. Am J Kidney Dis 1989;14:119-23.
8. Dlugosz BA, Bretan PN, Novick AC, Steinmuller SB, Streem K, Badwar K, et al. Causes of death in kidney transplant recipients: 1970 to present. Transplant Proc 1989;21:2168-70.
9. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumors in patients on chronic hemodialysis. Histopathology 1993;22:135-9.
10. Hughson MD, Schmidt L, Zbar B, Daugherty S, Meloni AM, Silva FG, et al. Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. J Am Soc Nephrol 1996;7:2461-8.
11. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper P, Cooper CS, et al. The Heidelberg classification of renal cell tumors. J Pathol 1997;183:131-3.
12. Storkel S, Eble JN, Adlakha K, Amin M, Blute ML, Bostwick DG, et al. Classification of renal cell carcinoma: workshop no. 1. Cancer 1997;80:987-9.
13. Hughson MD, Buchwald D, Fox M. Renal neoplasia and acquired cystic disease in patients receiving long-term dialysis. Arch Pathol Lab Med 1986;110:592-601.
14. McDougall ML, Welling LW, Weigmann TB. Prediction of carcinoma in acquired cystic disease as a function of kidney weight. J Am Soc Nephrol 1990;1:828-31.
15. Ishikawa I. Renal carcinoma in chronic hemodialysis patients: a 1990 questionnaire study in Japan. Kidney Int 1993; 34(Suppl 41):S167-S169.
16. Hughson MD, Hennigar GR, McManus JFA. Atypical cysts, acquired renal cystic disease, and renal cell tumors in end-stage dialysis kidneys. Lab Invest 1980;42:475-80.
17. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 1993;62:89-124.
18. Anglard P, Tory K, Brauch H, Weiss GH, Latif F, Merino MJ, et al. Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. Cancer Res 1991;51:1071-7.
19. Chudek J, Wilhelm M, Bugert P, Herbers J, Kovacs G. Detailed microsatellite analysis of chromosome 3p region in nonpapillary renal cell carcinomas. Int J Cancer 1997;73:225-9.
20. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
21. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, et al. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nat Genet 1994;7:85-90.
22. Jennings SB, Gnarra JR, Walther MM, Zbar B, Linehan WM. Renal cell carcinoma: molecular genetics and clinical implications. Surg Oncol Clin North Am 1995;4:219-29.
23. Gnarra JR, Lerman MI, Zbar B, Linehan WM. Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. Semin Oncol 1995;22:3-8.
24. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell tumors. Cancer Res 1994;54:2852-5.
25. Kovacs G, Fugezi L, Emanuel A, Kung H-F. Cytogenetics of papillary renal cell tumors. Genes Chromosom Cancer 1991; 3:249-55.
26. Palmedo G, Fischer J, Kovacs G. Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors. Lab Invest 1997;77:633-8.
27. Renshaw AA, Fletcher JA. Trisomy 3 in renal cell carcinoma. Mod Pathol 1997;10:481-4.
28. Bentz M, Bergerheim USR, Li C, Joos S, Werner CA, Baudis M, et al. Chromosome imbalance in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization. Cytogenet Cell Genet 1996;75:17-21.
29. Schmidt L, Dun FM, Chen F, Kishida T, Glenn G, Choyke P, et al. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal cell carcinomas. Nat Genet 1997;16:68-73.
30. Fischer J, Palmedo G, Bugert P, Prayer-Galeti T, Pagono F, Kovacs G. Duplication and overexpression of the mutant allele of the MET proto-oncogene in multiple hereditary papillary renal cell tumors. Oncogene 1998;17:733-9.
31. Hughson MD, Dickman K, Bigler SA, Meloni AM, Sandberg AA. Clear cell and papillary carcinoma of the kidney: an analysis of chromosomes 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization. Cancer Genet Cytogenet 1998;106:93-104.
32. Kovacs G, Brusa P. Clonal chromosomal abnormalities in normal kidney tissue from patients with renal cell carcinoma. Cancer Genet Cytogenet 1989;37:289-90.
33. Casalone R, Casalone PG, Minelli E, Portentoso P, Righi R, Meroni E, et al. Significance of the clonal and sporadic chromosomal abnormalities in non-neoplastic renal tissue. Hum Genet 1992;90:71-8.
34. Martin GM, Ogburn CE, Colgin LM, Gown AM, Edland SD, Monnat RJ. Somatic mutations are frequent and increase with age in human kidney epithelial cells. Hum Mol Genet 1996;5:215-21.
35. Kovacs G. Molecular differential pathology of renal cell tumors. Histopathology 1993;22:1-8.
36. Meloni AM, Bridge J, Sandberg AA. Reviews on chromosomal studies in urological tumors. I. Renal tumors. J Urol 1992; 148:253-65.
37. Ishikawa I, Shikura N, Ozaki M. Papillary renal cell carcinoma with numeric changes of chromosomes in a long-term hemodialysis patient: a karyotype analysis. Am J Kidney Dis 1993;21:553-6.
38. Chudek J, Herbers J, Kenck C, Wilhelm M, Bugert P, Ritz E, et al. The genetics and morphology of renal cell tumors in end-stage renal failure may differ from those occurring in the general population. J Am Soc Nephrol 1998;9:1045-51.
39. Kovacs G. High frequency of papillary renal cell tumors in end-stage kidneys: is there a molecular genetic explanation? Nephrol Dial Transplant 1995;10:593-6.
40. Kovacs G, Kovacs A. Parenchymal abnormalities associated with papillary renal cell tumors: a morphologic study. J Urol Pathol 1993;1:301-12.
41. Nadasdy T, Laszik Z, Blick KE, Johnson DL, Silva FG. Tubular atrophy in the end-stage kidney: a lectin and immunohistochemical study. Hum Pathol 1994;25:22-8.
42. Hughson MD, Meloni AM, Silva FG, Sandberg AA. Chromosomal abnormalities in a polycystic kidney: a mechanism for tumorigenesis in the end-stage kidney? [abstract]. Mod Pathol 1991;6:61A.
43. Herrera GA. C-erbB-2 amplification in cystic renal disease. Kidney Int 1991;40:509-13.
44. Klotz LH, Kulkarni C, Mills G. End-stage renal disease serum contains a specific renal cell growth factor. J Urol 1991;145: 156-60.
45. Moskowith DW, Bonar SL, Marcus MD, Clayman RV, Avner EC. Epidermal growth factor (EGF) content of human and mouse (CPK) renal cysts. Am J Kidney Dis 1989;14:435-6.
46. Grantham JJ, Levine E. Acquired cystic disease: replacing one kidney disease with another. Kidney Int 1985;28:99-105.
47. Levine E, Slusher SL, Grantham JJ, Wetzel LH. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. AJR 1991;156:501-6.